Improvement of comorbid anxiety and depression in patients with migraine treated with injectable preventive calcitonin gene-related peptide antagonists: Review of clinical evidence

• Asıl Yazarlar: Abubker Omaer (Yazar), Abdulrazaq Albilali (Yazar), Reem Bamogaddam (Yazar), Fares Almutairi (Yazar), Raghad Alsaif (Yazar), Osama Almohammadi (Yazar), Abdullah A Alhifany (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: Elsevier, 2024-04-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Background: Migraine is often associated with depression and anxiety, leading to a diminished quality of life. Calcitonin gene‐related peptide (CGRP) antagonists have shown promise in treating migraines, but their effects on concurrent depression and anxiety have not been clarified. Methods: A liter...